Fernando Moreno
YOU?
Author Swipe
View article: P11.13.B INTRAOPERATIVE DISCRIMINATION OF TUMOR MARGINS IN BRAIN METASTASES USING A LABEL-FREE NANOPLASMONIC BIOSENSOR, A PROOF OF CONCEPT.
P11.13.B INTRAOPERATIVE DISCRIMINATION OF TUMOR MARGINS IN BRAIN METASTASES USING A LABEL-FREE NANOPLASMONIC BIOSENSOR, A PROOF OF CONCEPT. Open
BACKGROUND Complete resection of brain metastases may be challenging in infiltrative lesions lacking a clear tumor-parenchyma border. Current intraoperative tools to discriminate the margins usually need exogenous contrast agents, often ha…
View article: Optical discrimination of live single cancer cells using reflection-based nanohole array sensor
Optical discrimination of live single cancer cells using reflection-based nanohole array sensor Open
View article: The Granada-Amsterdam Light Scattering Database: Experimental optical properties of cosmic dust analogue samples.
The Granada-Amsterdam Light Scattering Database: Experimental optical properties of cosmic dust analogue samples. Open
The characterization of dust particles in the Solar System is a fundamental component of planetary science. These particles are present in a variety of environments, including the atmospheres of planets and satellites, comets, or covering …
View article: Photometry and spectroscopy of distant comet C/2014 N3 (NEOWISE)
Photometry and spectroscopy of distant comet C/2014 N3 (NEOWISE) Open
Context . We analyzed spectral and photometric data of comet C/2014 N3 (NEOWISE) to investigate its physical properties and activity at a heliocentric distance of 4.51 au. Aims . The aim of the analysis was to detect gas emissions and dete…
View article: Dust shells and dark linear structures on dust tails of historical and recent long-period comets
Dust shells and dark linear structures on dust tails of historical and recent long-period comets Open
Context. Dust halos or shells, along with linear dark structures along the axes of dust tails, are commonly observed in many long- period comets near perihelion. Examples range from the recent C/2023 A3 (Tsuchinshan-ATLAS) to historical co…
View article: Dust shells and dark linear structures on dust tails of historical and recent long-period comets
Dust shells and dark linear structures on dust tails of historical and recent long-period comets Open
Context. Dust halos or shells, along with linear dark structures along the axes of dust tails, are commonly observed in many long-period comets near perihelion. Examples range from the recent C/2023 A3 (Tsuchinshan-ATLAS) to historical com…
View article: COMetary dust TAIL Simulator (COMTAILS): A computer code to generate comet dust tail brightness images
COMetary dust TAIL Simulator (COMTAILS): A computer code to generate comet dust tail brightness images Open
Context. We present the COMetary dust TAIL Simulator ( COMTAILS ), a numerical Monte Carlo code to generate images of dust tail brightness from comets and active asteroids in the Solar System. Aims. We describe a numerical code, available …
View article: Interlaboratory study on Sb2S3 interplay between structure, dielectric function, and amorphous-to-crystalline phase change for photonics
Interlaboratory study on Sb2S3 interplay between structure, dielectric function, and amorphous-to-crystalline phase change for photonics Open
View article: Unveiling Polymorphs and Polytypes of the 2D Layered Semiconducting Gallium Monosulfide
Unveiling Polymorphs and Polytypes of the 2D Layered Semiconducting Gallium Monosulfide Open
Polymorphism is gaining attention among van der Waals layered materials. In the case of gallium monosulfide, a hexagonal phase has predominantly been reported. Here the successful growth of rhombohedral gallium sulfide (GaS) with space gro…
View article: Correction: Rosales et al. Non-Absorbing Dielectric Materials for Surface-Enhanced Spectroscopies and Chiral Sensing in the UV. Nanomaterials 2020, 10, 2078
Correction: Rosales et al. Non-Absorbing Dielectric Materials for Surface-Enhanced Spectroscopies and Chiral Sensing in the UV. Nanomaterials 2020, 10, 2078 Open
In the published study [...]
View article: Sb2S3-Based Optical Switch Exploiting the Brewster Angle Phenomenon
Sb2S3-Based Optical Switch Exploiting the Brewster Angle Phenomenon Open
Optical switches based on phase change materials (PCMs) hold great promise for various photonic applications such as telecommunications, data communication, optical interconnects, and signal processing. Their non-volatile nature as well as…
View article: Sb<sub>2</sub>S<sub>3</sub>-based optical switch exploiting the Brewster angle phenomenon [Invited]
Sb<sub>2</sub>S<sub>3</sub>-based optical switch exploiting the Brewster angle phenomenon [Invited] Open
Optical switches based on phase change materials (PCMs) hold great promise for various photonic applications such as telecommunications, data communication, optical interconnects, and signal processing. Their non-volatile nature as well as…
View article: Discriminating Glioblastoma from Peritumoral Tissue by a Nanohole Array-Based Optical and Label-Free Biosensor
Discriminating Glioblastoma from Peritumoral Tissue by a Nanohole Array-Based Optical and Label-Free Biosensor Open
In glioblastoma (GBM) patients, maximal safe resection remains a challenge today due to its invasiveness and diffuse parenchymal infiltration. In this context, plasmonic biosensors could potentially help to discriminate tumor tissue from p…
View article: Data from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Data from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Open
Purpose: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin to anthracycline/taxane chemotherapy improves pathologic complete response (pCR) in triple-negative breast cancer (TNBC). Effectiveness of anthracycli…
View article: Figure S2 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Figure S2 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Recurrence-free survival and overall survival in the overall patient population
View article: Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Open
Supplemental material contains names of participating institutions for the Spanish MMJ-CAR-2014-01 cohort, details on local guidelines for positive family history, tables depicting the relationship between pathological response and family …
View article: Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Open
Supplemental material contains names of participating institutions for the Spanish MMJ-CAR-2014-01 cohort, details on local guidelines for positive family history, tables depicting the relationship between pathological response and family …
View article: Data from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Data from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Open
Purpose: Triple-negative breast cancer (TNBC) requires the iden- tification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we aimed to evaluate the performance of the TNBCtype-4 classifier i…
View article: Figure S3 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Figure S3 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Recurrence-free survival and overall survival by adjuvant chemotherapy use in RCB II/III patients
View article: Data from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Data from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Purpose:Prognostic value of pathologic complete response (pCR) and extent of pathologic response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is unknown. We re…
View article: Figure S1 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Figure S1 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Pathological response to carboplatin plus docetaxel by germline BRCA status
View article: Table S1 from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Table S1 from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Open
Table S1 Response among mutation carriers among mutation carriers (number of patients.)
View article: Supplementary Methods and Results from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Supplementary Methods and Results from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Further description of patient population and exploratory analysis.
View article: Supplementary Methods and Results from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Supplementary Methods and Results from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Further description of patient population and exploratory analysis.
View article: Table S1 from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Table S1 from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Open
Table S1 Response among mutation carriers among mutation carriers (number of patients.)
View article: Data from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Data from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Purpose:Prognostic value of pathologic complete response (pCR) and extent of pathologic response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is unknown. We re…
View article: Data from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Data from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Open
Purpose: Triple-negative breast cancer (TNBC) requires the iden- tification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we aimed to evaluate the performance of the TNBCtype-4 classifier i…
View article: Data from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Data from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Open
Purpose: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin to anthracycline/taxane chemotherapy improves pathologic complete response (pCR) in triple-negative breast cancer (TNBC). Effectiveness of anthracycli…
View article: Figure S1 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Figure S1 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Pathological response to carboplatin plus docetaxel by germline BRCA status
View article: Figure S2 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Figure S2 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Open
Recurrence-free survival and overall survival in the overall patient population